Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Deutsche Boerse AG
  5. MPH Health Care AG
  6. News
  7. Summary
    93M1   DE000A289V03

MPH HEALTH CARE AG

(93M1)
  Report
Delayed Quote. Delayed Deutsche Boerse AG - 07/23 02:01:05 am
28.4 EUR   +4.03%
06/11ORIGINAL-RESEARCH : MPH Health Care AG (von First Berlin Equity Research GmbH): Buy
DJ
06/02PRESS RELEASE : MPH Health Care AG: result Q1-2021
DJ
06/02MPH HEALTH CARE AG : result Q1-2021
EQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

PRESS RELEASE: MPH Health Care AG: result Q1-2021

06/02/2021 | 02:33am EDT
DGAP-News: MPH Health Care AG / Key word(s): Quarterly / Interim Statement/Miscellaneous 
MPH Health Care AG: result Q1-2021 
2021-06-02 / 08:30 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
MPH Health Care AG: result Q1-2021 
MPH Health Care AG with a good start into the year: EBIT amounts to EUR 22.5 million in Q1. Equity (net asset value) 
rises to EUR 223.4 million, corresponding to EUR 52.19 per share. 
Berlin, 2 June 2021: In the first quarter of 2021, MPH Health Care AG (ISIN: DE000A289V03) benefited from the recovery 
of the stock market prices of its listed investments and achieved an operating result (EBIT) according to IFRS of EUR 
22.5 million (same period previous year: EUR -88.4 million). 
Equity increased by 11.0% to EUR 223.4 million (31.12.2020: EUR 201.3 million). Net asset value (NAV) per share 
increased accordingly from EUR 47.01 to EUR 52.19. The equity ratio as at 31.03.2021 increased slightly to 96.0% 
(31.12.2020: 95.5%). 
The investment M1 Kliniken AG had a successful start into the year 2021 with a significant increase in revenues and 
earnings in the two business segments "Beauty" and "Trade". Consolidated revenue rose to around EUR 81 million in the 
first quarter of 2021 (previous year EUR 23 million) and EBITDA to EUR 4.0 million (previous year EUR 1.4 million). 
In the Beauty segment, the new year had a slow start (due to the ongoing Corona pandemic) with treatment figures around 
20% below the previous year. However, by the end of the quarter, M1 was back to historic peak daily sales and continued 
to grow. In Q1-2021 as a whole, almost 81 thousand treatments were carried out compared to 73 thousand treatments in 
the same quarter of the previous year. By the end of May 2021, four new specialist centers had already been opened in 
the German market. According to current planning, a total of 50 M1 specialist centers are planned by the end of 2021, 
with further locations also opening in foreign markets. 
In the trading segment, the operational optimization of the business activities of HAEMATO AG continued, which was able 
to report an increase in turnover in the past quarter compared to the previous year. In the process, HAEMATO AG was 
able to significantly improve its profitability. The share price of M1 Kliniken AG improved from 9.24 euros on 31 
December 2020 to 10.85 euros on 31 March 2021. 
Our second listed investment CR Capital AG (formerly CR Capital Real Estate AG) was also able to continue on its 
successful path in 2021 - almost unaffected by the COVID-19 pandemic - and continued to grow profitably. In the first 
three months, CR Capital was already able to notarially sell 161 residential units with a sales volume of approx. EUR 
54 million in the projects Rousseau Park in the Berlin suburbs and Leipzig-Schkeuditz via participation Terrabau. The 
share price of CR Capital AG has increased from EUR 30.50 on 31 December 2020 to EUR 32.50 on 31 March 2021. 
With an increasing easing of the Corona restrictions due to rising vaccination rates and falling case numbers, we are 
confident about the further development of our investments. All M1 Med Beauty locations in Germany and abroad have been 
reopened in the meantime, HAEMATO AG is making an important contribution to the Corona pandemic with the sale of 
medical products for Covid-19 diagnostics, and CR Capital AG has so far been able to record a continually strong demand 
for affordable residential real estate. 
Due to the ongoing Corona pandemic, MPH Health Care AG will make use of the option to invite shareholders to the 
company's Annual General Meeting scheduled for 15 July 2021 with a shortened notice period of 21 days. 
About MPH Health Care AG: 
MPH AG is an investment company with a strategic focus on the purchase, development and sale of companies and company 
shares, especially in growth segments of the health care market. This includes both insurance-financed and privately 
financed segments. However, MPH also exploits potentials outside the healthcare market from high-growth and high-yield 
sectors. 
MPH Health Care AG is listed on the Basic Board (Open Market) of the Frankfurt Stock Exchange. 
Contact: 
Patrick Brenske, Management Board 
Corporate Communications 
E-Mail: ir@mph-ag.de 
=---------------------------------------------------------------------------------------------------------------------- 
2021-06-02 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. 
Archive at www.dgap.de 
=---------------------------------------------------------------------------------------------------------------------- 
Language:     English 
Company:      MPH Health Care AG 
              Grünauer Straße 5 
              12557 Berlin 
              Germany 
Phone:        030 / 863 21 45 60 
Fax:          030 / 863 21 45 69 
E-mail:       info@mph-ag.de 
Internet:     www.mph-ag.de 
ISIN:         DE000A289V03, DE000A289VT5 
WKN:          A289V0 
Listed:       Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Munich, Stuttgart, Tradegate 
              Exchange 
EQS News ID:  1203367 
 
End of News   DGAP News Service 
=------------ 

1203367 2021-06-02

 
Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1203367&application_name=news 
 

(END) Dow Jones Newswires

June 02, 2021 02:32 ET (06:32 GMT)

Stocks mentioned in the article
ChangeLast1st jan.
CR CAPITAL AG -1.22% 32.5 Delayed Quote.6.56%
DJ INDUSTRIAL 0.68% 35061.55 Delayed Quote.13.78%
HAEMATO AG 0.37% 27.3 End-of-day quote.18.70%
M1 KLINIKEN AG 1.64% 9.9 Delayed Quote.7.14%
MPH HEALTH CARE AG 4.03% 28.4 Delayed Quote.24.56%
All news about MPH HEALTH CARE AG
06/11ORIGINAL-RESEARCH : MPH Health Care AG (von First Berlin Equity Research GmbH): ..
DJ
06/02PRESS RELEASE : MPH Health Care AG: result Q1-2021
DJ
06/02MPH HEALTH CARE AG : result Q1-2021
EQ
05/28Mph Health Care Ag Reports Earnings Results for the Full Year Ended December ..
CI
05/28MPH HEALTH CARE : Annual Report 2020
PU
05/06ORIGINAL-RESEARCH : MPH Health Care AG (von First Berlin Equity Research GmbH): ..
DJ
04/28PRESS RELEASE : MPH Health Care AG: Preliminary IFRS result 2020
DJ
04/28MPH HEALTH CARE AG : Preliminary IFRS result 2020
EQ
2020ORIGINAL-RESEARCH : MPH Health Care AG (von First Berlin Equity Research GmbH): ..
DJ
2020EQS/ORIGINAL-RESEARCH : MPH Health Care AG (von First Berlin Equity Research Gmb..
DJ
More news
Financials
Sales 2021 44,8 M 52,8 M 52,8 M
Net income 2021 40,6 M 47,7 M 47,7 M
Net Debt 2021 - - -
P/E ratio 2021 30,0x
Yield 2021 5,28%
Capitalization 122 M 143 M 143 M
Capi. / Sales 2021 2,71x
Capi. / Sales 2022 5,07x
Nbr of Employees 424
Free-Float 50,0%
Chart MPH HEALTH CARE AG
Duration : Period :
MPH Health Care AG Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 28,40 €
Average target price 75,00 €
Spread / Average Target 164%
EPS Revisions
Managers and Directors
Patrick Brenske Chairman-Management Board
Andrea Grosse Chairman-Supervisory Board
Sabine Meck Member-Supervisory Board
Ulrich Wandschneider Deputy Chairman-Supervisory Board